**
The Principal Scientist, Clinical Research position at Mericalherbs focuses on leading strategic planning and directing clinical research activities in Immunology, particularly during late-stage development. The ideal candidate will have substantial experience in clinical trial design and execution, especially in rheumatologic diseases, while benefiting from a collaborative and inclusive company culture.
**
Job Summary
The Clinical Director has primary responsibility for the strategic planning and directing clinical research activities involving investigational compounds in Immunology, with a focus on late-stage development.
Responsibilities include managing the entire cycle of clinical development, from disease indication determination to study design, execution, monitoring, analysis, regulatory filing, and publication.
The company offers a comprehensive package of benefits including medical, dental, vision healthcare, retirement benefits, paid holidays, vacation, and compassionate and sick days.
Matching Summary
Match Score: 75
**
The Principal Scientist, Clinical Research position at Mericalherbs focuses on leading strategic planning and directing clinical research activities in Immunology, particularly during late-stage development. The ideal candidate will have substantial experience in clinical trial design and execution, especially in rheumatologic diseases, while benefiting from a collaborative and inclusive company culture.
**
Salary
Base: $250,800.00 - $394,800.00; Bonus/Equity: eligible for annual bonus and long-term incentive; Benefits: comprehensive package of benefits
Skills & Requirements
Must-have
Clinical development strategies
Late-stage development
Immunology pipeline
Clinical trial design
Regulatory filing support
Nice-to-have
Strong scientific fund of knowledge
Cross-functional team collaboration
External expert relationships
Intellectual curiosity
Key Requirements
Minimum of 5 years of clinical and/or development experience
Demonstrated record of scientific scholarship and achievement
Prior experience in design and execution of phase 2 or 3 clinical trials in rheumatologic diseases is preferred